Related Experiment Videos
Eosinophils: from low- to high-affinity immunoglobulin E receptors
M Capron1, A Soussi Gounni, M Morita
1Centre d'Immunologie et de Biologie Parasitaire, Unité INSERM U 167, Institut Pasteur, Lille, France.
Allergy
|January 1, 1995
Summary
Human eosinophils express multiple immunoglobulin E (IgE) binding molecules, including Fc epsilon RII/CD23, S-type lectins, and Fc epsilon RI. These molecules play roles in IgE binding, cytotoxicity, and parasitic infection immunity.
Area of Science:
- Immunology
- Cell Biology
- Parasitology
Background:
- Human eosinophils are key immune cells involved in defense against parasites and allergic responses.
- Immunoglobulin E (IgE) plays a critical role in these responses, primarily through its interaction with eosinophils.
Purpose of the Study:
- To identify and characterize the various immunoglobulin E (IgE) binding molecules expressed by human eosinophils.
- To elucidate the functional roles of these IgE binding molecules in eosinophil-mediated immune responses, particularly against parasitic infections.
Main Methods:
- Experimental approaches including immunological assays and detection of molecular components.
- Use of monoclonal antibodies to investigate functional roles.
- Analysis of Fc epsilon RI expression in hypereosinophilic patients.
Main Results:
- Fc epsilon RII/CD23 and S-type lectins (Mac2/epsilon binding proteins) were identified on eosinophils, with Mac2 inhibiting cytotoxicity.
- Fc epsilon RI (alpha, beta, gamma chains) was detected on eosinophils, particularly in hypereosinophilic patients.
- The Fc epsilon RI alpha chain mediates IgE binding and eosinophil peroxidase release, suggesting a role in protective immunity against parasites.
Conclusions:
- Human eosinophils express multiple IgE binding receptors, contributing to diverse immune functions.
- Fc epsilon RI on eosinophils has a previously unrecognized role in protective immunity against parasitic infections.
- Understanding these interactions is crucial for developing targeted therapies for parasitic diseases and allergic disorders.